Pinnacle Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Buy |
5,122
+810
| +19% | +$63.4K | 0.01% | 676 |
|
|
2025
Q1 | $313K | Sell |
4,312
-167
| -4% | -$12.1K | ﹤0.01% | 706 |
|
|
2024
Q4 | $332K | Sell |
4,479
-1,056
| -19% | -$78.2K | ﹤0.01% | 691 |
|
|
2024
Q3 | $422K | Sell |
5,535
-178
| -3% | -$13.6K | 0.01% | 604 |
|
|
2024
Q2 | $528K | Sell |
5,713
-5
| -0.1% | -$462 | 0.01% | 575 |
|
|
2024
Q1 | $546K | Buy |
5,718
+183
| +3% | +$17.5K | 0.01% | 569 |
|
|
2023
Q4 | $422K | Sell |
5,535
-193
| -3% | -$14.7K | 0.01% | 612 |
|
|
2023
Q3 | $397K | Sell |
5,728
-598
| -9% | -$41.4K | 0.01% | 597 |
|
|
2023
Q2 | $597K | Buy |
6,326
+248
| +4% | +$23.4K | 0.01% | 553 |
|
|
2023
Q1 | $503K | Buy |
6,078
+795
| +15% | +$65.8K | 0.01% | 517 |
|
|
2022
Q4 | $394K | Buy |
5,283
+336
| +7% | +$25.1K | 0.01% | 554 |
|
|
2022
Q3 | $409K | Buy |
4,947
+168
| +4% | +$13.9K | 0.01% | 534 |
|
|
2022
Q2 | $454K | Buy |
4,779
+971
| +25% | +$92.2K | 0.01% | 535 |
|
|
2022
Q1 | $448K | Buy |
+3,808
| New | +$448K | 0.01% | 585 |
|
|
2020
Q1 | – | Sell |
-3,285
| Closed | -$255K | – | 673 |
|
|
2019
Q4 | $255K | Hold |
3,285
| – | – | 0.01% | 624 |
|
|
2019
Q3 | $241K | Buy |
+3,285
| New | +$241K | 0.01% | 631 |
|
|
2019
Q1 | – | Sell |
-5,055
| Closed | -$258K | – | 717 |
|
|
2018
Q4 | $258K | Hold |
5,055
| – | – | 0.01% | 601 |
|
|
2018
Q3 | $293K | Hold |
5,055
| – | – | 0.01% | 606 |
|
|
2018
Q2 | $245K | Hold |
5,055
| – | – | 0.01% | 626 |
|
|
2018
Q1 | $235K | Buy |
+5,055
| New | +$235K | ﹤0.01% | 610 |
|